Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v7-EN | Version v3-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2022-09-28 | 2022-08-02 |
| Drug Identification Number | 02301903 | 02301903 |
| Brand name | CIPROFLOXACIN INJECTION USP | CIPROFLOXACIN INJECTION USP |
| Common or Proper name | CIPROFLOXACIN INJECTION USP | CIPROFLOXACIN INJECTION USP |
| Company Name | PFIZER CANADA ULC | PFIZER CANADA ULC |
| Ingredients | CIPROFLOXACIN | CIPROFLOXACIN |
| Strength(s) | 2MG | 2MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 24 x 200mL bag | 24 x 200ml bag |
| ATC code | J01MA | J01MA |
| ATC description | QUINOLONE ANTIBACTERIALS | QUINOLONE ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2022-08-01 | 2022-08-01 |
| Actual start date | 2022-08-01 | |
| Estimated end date | Unknown | |
| Actual end date | 2022-09-27 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Product is discontinued. | |
| Health Canada comments |